Last reviewed · How we verify
Depressive disorder
Approved treatments
- Auromid
- Humoryl
- Tecipul
Tecipul is thought to work by modulating neurotransmitter activity in the brain. - Iprazid
Iproniazid works by blocking the enzyme that breaks down certain neurotransmitters, allowing their levels to increase in the brain. - Norpramin · Validus Pharms
- Amoxan · Pfizer
- Amineptin
- Timostenil
Timostenil is thought to work by modulating neurotransmitter activity in the brain. - Spravato · Yale University
- Spravato · Johnson & Johnson
Spravato works by blocking the action of glutamate, a neurotransmitter involved in mood regulation. - Opramidol
Opipramol works by binding to the sigma non-opioid intracellular receptor 1, which helps to regulate mood and emotional responses. - Lopramine
- Actomol
- Butriptylene
Butriptyline works by blocking the reuptake of serotonin, a neurotransmitter involved in mood regulation, allowing more serotonin to be available in the brain. - Deparon
Deparon is thought to work by influencing neurotransmitter levels in the brain. - Iproclozid
Iproclozide works by blocking the enzyme that breaks down certain neurotransmitters in the brain, allowing their levels to increase and improve mood. - Meilax
Meilax works by enhancing the activity of a neurotransmitter called gamma-aminobutyric acid (GABA), which helps to calm the brain and reduce anxiety. - Sertralin · Poznan University of Medical Sciences
- Prozac · RenJi Hospital
- Wellbutrin · GSK (GlaxoSmithKline)
Norepinephrine-dopamine reuptake inhibitor (NDRI) that treats depression and aids smoking cessation without serotonergic side effects. - Triptil
- MAPROTILINE
- Aventyl
- Tofranil
- Nardil · Pfizer
- Celexa · AbbVie
Celexa works by blocking the reabsorption of serotonin in the brain, allowing more of this neurotransmitter to be available for communication between nerve cells. - Zonalon
Zonalon works by blocking histamine H1 receptors in the brain, which helps to reduce anxiety and itching, and improve mood. - Aventyl
- Nardil · Pfizer
- Surmontil · Teva Womens
- Zoloft · Pfizer Inc.
Selective serotonin reuptake inhibitor (SSRI) that blocks the serotonin transporter, increasing synaptic serotonin to improve mood and reduce anxiety. - Endep · AstraZeneca
- Prozac · Eli Lilly and Company
Fluoxetine inhibits CNS neuronal uptake of serotonin, though exact mechanism unknown. - Cital · Ain Shams University
- Amitryptiline · Mahatma Gandhi Institute of Medical Sciences
- Wellbutrin · Mclean Hospital
- Elontril · Boehringer Ingelheim
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Depressive disorder patent landscape — cliff calendar, originator estates, attackable patents
- Depressive disorder treatment landscape brief
- Depressive disorder treatment updates RSS
Frequently asked questions about Depressive disorder
What drugs treat Depressive disorder?
Tracked treatments include Auromid, Humoryl, Tecipul, Iprazid, Norpramin, Amoxan, Amineptin, Timostenil.
What is the treatment for Depressive disorder?
Standard treatment for Depressive disorder includes Auromid, Humoryl, Tecipul, Iprazid, Norpramin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Depressive disorder patent cliff · Depressive disorder CI report
- Treatment: Auromid
- Treatment: Humoryl
- Treatment: Tecipul
- Treatment: Iprazid
- Treatment: Norpramin · Validus Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing